Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-11-06
2000-02-22
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514256, 514269, 514274, 514275, 514340, 544316, 544319, 544329, 544332, 5462714, 548229, 548232, A61K 3142, A61K 31505, C07D26308, C07D23902
Patent
active
060280905
ABSTRACT:
Novel oxazolidinone derivatives of the formula I ##STR1## in which R.sup.1 is a phenyl radical which is unsubstituted or is monosubstituted by CN, H.sub.2 N--CH.sub.2 --, A.sub.2 N--CH.sub.2 --, H.sub.2 N--C(.dbd.NH)--, H.sub.2 N--C(.dbd.NH)--NH--, H.sub.2 N--C(.dbd.NH)--NH--CH.sub.2 --, HO--NH--C(.dbd.NH)-- or HO--NH--C(.dbd.NH)--NH--,
REFERENCES:
patent: 5232931 (1993-08-01), Prucher et al.
patent: 5480899 (1996-01-01), Yano et al.
patent: 5561148 (1996-10-01), Gante et al.
patent: 5719145 (1998-02-01), Yamashita et al.
patent: 5824691 (1998-10-01), Kuno et al.
Burger et al, Medicinal Chemistry 2d Ed Interscience, NY 1960 p. 42.
Iwakura et al., Chem. Abstr., vol. 64, entry 8163a(1964).
Iwakura et al., Chem. Abstr., vol. 67, entry 108577(1966).
Burger, "Medicinal Chemistry," 2d. ed., Inter-Science, NY, 1960, p. 42.
"Low Molecular Weight, Non-Peptide Fibrinogen Receptor Antagonists," Alig et al., J. Med. Chem., vol. 35, 1992, pp. 4393-4407.
"Potent in Vitro and in Vivo Inhibitors of Platelet Aggregation Based Upon the Arg-Gly-Asp-Phe Sequence of Fibrinogen. A Proposal on the Nature of the Binding Interaction Between the Arg-Guanidine of RGDX Mimetics and the Platelet GP IIb-IIIa Receptor." Zablocki et al., J. Med. Chem., vol. 36, 1993, pp. 1811-1819.
Iwakura et al., Bull. Chem. Soc. Japan, vol. 39, pp. 2490-2494(1966).
Bernotat-Danielowski Sabine
Gante Joachim
Juraszyk Horst
Melzer Guido
Raddatz Peter
Coleman Brenda
Merck Patent Gesellschaft mit beschrankter Haftung
Shah Mukund J.
LandOfFree
Adhesion receptor antagonists III does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adhesion receptor antagonists III, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adhesion receptor antagonists III will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-520824